New Strategies to Expand and Optimize Heart Donor Pool: Ex Vivo Heart Perfusion and Donation After Circulatory Death: A Review of Current Research and Future Trends
- PMID: 30531220
- DOI: 10.1213/ANE.0000000000003919
New Strategies to Expand and Optimize Heart Donor Pool: Ex Vivo Heart Perfusion and Donation After Circulatory Death: A Review of Current Research and Future Trends
Abstract
Heart transplantation remains the definitive management for end-stage heart failure refractory to medical therapy. While heart transplantation cases are increasing annually worldwide, there remains a deficiency in organ availability with significant patient mortality while on the waiting list. Attempts have therefore been made to expand the donor pool and improve access to available organs by recruiting donors who may not satisfy the standard criteria for organ donation because of donor pathology, anticipated organ ischemic time, or donation after circulatory death. "Ex vivo" heart perfusion (EVHP) is an emerging technique for the procurement of heart allografts. This technique provides mechanically supported warm circulation to a beating heart once removed from the donor and before implantation into the recipient. EVHP can be sustained for several hours, facilitate extended travel time, and enable administration of pharmacological agents to optimize cardiac recovery and function, as well as allow assessment of allograft function before implantation. In this article, we review recent advances in expanding the donor pool for cardiac transplantation. Current limitations of conventional donor criteria are outlined, including the determinants of organ suitability and assessment, involving transplantation of donation after circulatory death hearts, extended criteria donors, and EVHP-associated assessment, optimization, and transportation. Finally, ongoing research relating to organ optimization and functional ex vivo allograft assessment are reviewed.
Similar articles
-
Ex vivo perfusion of the donor heart: Preliminary experience in high-risk transplantations.Arch Cardiovasc Dis. 2021 Nov;114(11):715-726. doi: 10.1016/j.acvd.2021.07.003. Epub 2021 Oct 5. Arch Cardiovasc Dis. 2021. PMID: 34620574
-
Adult heart transplantation with distant procurement and ex-vivo preservation of donor hearts after circulatory death: a case series.Lancet. 2015 Jun 27;385(9987):2585-91. doi: 10.1016/S0140-6736(15)60038-1. Epub 2015 Apr 14. Lancet. 2015. PMID: 25888085
-
Donation after circulatory death heart transplantation.Curr Opin Organ Transplant. 2017 Jun;22(3):189-197. doi: 10.1097/MOT.0000000000000419. Curr Opin Organ Transplant. 2017. PMID: 28379853 Review.
-
A Rodent Model of Cardiac Donation After Circulatory Death and Novel Biomarkers of Cardiac Viability During Ex Vivo Heart Perfusion.Transplantation. 2017 Aug;101(8):e231-e239. doi: 10.1097/TP.0000000000001815. Transplantation. 2017. PMID: 28505025
-
Donation After Circulatory Death Heart Transplantation: A Narrative Review.J Cardiothorac Vasc Anesth. 2024 Sep;38(9):2047-2058. doi: 10.1053/j.jvca.2024.03.045. Epub 2024 Apr 3. J Cardiothorac Vasc Anesth. 2024. PMID: 38981770 Review.
Cited by
-
Strategies for Expanding Donors Pool in Heart Transplantation.Rev Cardiovasc Med. 2022 Aug 15;23(8):285. doi: 10.31083/j.rcm2308285. eCollection 2022 Aug. Rev Cardiovasc Med. 2022. PMID: 39076623 Free PMC article. Review.
-
Donor Heart Preservation: Current Knowledge and the New Era of Machine Perfusion.Int J Mol Sci. 2023 Nov 24;24(23):16693. doi: 10.3390/ijms242316693. Int J Mol Sci. 2023. PMID: 38069017 Free PMC article. Review.
-
Normothermic ex vivo heart perfusion with NLRP3 inflammasome inhibitor Mcc950 treatment improves cardiac function of circulatory death hearts after transplantation.Front Cardiovasc Med. 2023 Mar 17;10:1126391. doi: 10.3389/fcvm.2023.1126391. eCollection 2023. Front Cardiovasc Med. 2023. PMID: 37008319 Free PMC article.
-
Normothermic ex vivo Heart Perfusion Combined With Melatonin Enhances Myocardial Protection in Rat Donation After Circulatory Death Hearts via Inhibiting NLRP3 Inflammasome-Mediated Pyroptosis.Front Cell Dev Biol. 2021 Aug 31;9:733183. doi: 10.3389/fcell.2021.733183. eCollection 2021. Front Cell Dev Biol. 2021. PMID: 34532321 Free PMC article.
-
Zebrafish as a New Tool in Heart Preservation Research.J Cardiovasc Dev Dis. 2021 Apr 8;8(4):39. doi: 10.3390/jcdd8040039. J Cardiovasc Dev Dis. 2021. PMID: 33917701 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical